Changes in women's physical function in mid-life by reproductive age and hormones: a longitudinal study.


Journal

BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690

Informations de publication

Date de publication:
24 11 2022
Historique:
received: 22 07 2022
accepted: 27 09 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 30 11 2022
Statut: epublish

Résumé

Whether women's physical function in mid-life is related to their reproductive age is not known. The objectives of this study were to examine and compare changes in physical function in women by reproductive age, measured as time since final menstrual period (FMP), and chronological age, and to explore associations with repeatedly assessed levels of reproductive hormones. We used data from 2319 UK women with up to three repeated measurements of physical function (median length of follow up: 2 years), focusing on changes occurring in women experiencing a natural menopausal transition. The main outcome was a composite physical function score that incorporated assessments of strength (grip strength), balance (one-leg stand) and cardiorespiratory fitness (timed chair rises). Associations with time since FMP, age, and time-updated measures of anti-Müllerian hormone, follicle-stimulating hormone and luteinizing hormone were assessed by multilevel models and generalised estimating equations models adjusted for the underlying effects of chronological age and confounding by education, age at first birth and smoking. The results showed that, adjusted for these confounders, time since FMP (- 0.21 SD per 10 years, 95% CI - 0.37, - 0.06) and chronological age (- 0.31 SD per 10 years, 95% CI - 0.46, - 0.15) were inversely associated with the physical function composite score. Grip strength seemed to be the main contributor to the decline in the composite score by time since FMP. There was no strong evidence of associations between any of the three reproductive hormones and the composite score. Physical function in women in mid-life declined with both chronological and reproductive age. The decline with reproductive age was independent of chronological age but did not seem to be driven by changes in reproductive hormones.

Sections du résumé

BACKGROUND
Whether women's physical function in mid-life is related to their reproductive age is not known. The objectives of this study were to examine and compare changes in physical function in women by reproductive age, measured as time since final menstrual period (FMP), and chronological age, and to explore associations with repeatedly assessed levels of reproductive hormones.
METHODS
We used data from 2319 UK women with up to three repeated measurements of physical function (median length of follow up: 2 years), focusing on changes occurring in women experiencing a natural menopausal transition. The main outcome was a composite physical function score that incorporated assessments of strength (grip strength), balance (one-leg stand) and cardiorespiratory fitness (timed chair rises). Associations with time since FMP, age, and time-updated measures of anti-Müllerian hormone, follicle-stimulating hormone and luteinizing hormone were assessed by multilevel models and generalised estimating equations models adjusted for the underlying effects of chronological age and confounding by education, age at first birth and smoking.
RESULTS
The results showed that, adjusted for these confounders, time since FMP (- 0.21 SD per 10 years, 95% CI - 0.37, - 0.06) and chronological age (- 0.31 SD per 10 years, 95% CI - 0.46, - 0.15) were inversely associated with the physical function composite score. Grip strength seemed to be the main contributor to the decline in the composite score by time since FMP. There was no strong evidence of associations between any of the three reproductive hormones and the composite score.
CONCLUSIONS
Physical function in women in mid-life declined with both chronological and reproductive age. The decline with reproductive age was independent of chronological age but did not seem to be driven by changes in reproductive hormones.

Identifiants

pubmed: 36434722
doi: 10.1186/s12905-022-02070-9
pii: 10.1186/s12905-022-02070-9
pmc: PMC9700972
doi:

Substances chimiques

Follicle Stimulating Hormone 9002-68-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

473

Subventions

Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202802/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001357
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

J Clin Med. 2020 May 23;9(5):
pubmed: 32456169
PLoS One. 2011;6(11):e27899
pubmed: 22114723
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
J Aging Health. 2010 Aug;22(5):589-610
pubmed: 20453156
J Chronic Dis. 1987;40(2):115-20
pubmed: 3818864
JAMA. 1999 Feb 10;281(6):558-60
pubmed: 10022113
PLoS One. 2015 Mar 30;10(3):e0119480
pubmed: 25822526
J Am Geriatr Soc. 2001 Nov;49(11):1485-92
pubmed: 11890587
PLoS One. 2014 Dec 04;9(12):e113637
pubmed: 25474696
J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
pubmed: 10811152
Bone. 2019 Jun;123:137-144
pubmed: 30930293
J Clin Endocrinol Metab. 2011 Mar;96(3):746-54
pubmed: 21159842
Am J Obstet Gynecol. 2019 Nov;221(5):393-409.e50
pubmed: 31034807
Menopause. 2019 Sep;26(9):958-965
pubmed: 31453956
J Gerontol A Biol Sci Med Sci. 2017 Apr 01;72(4):572-578
pubmed: 27356977
BMJ. 2010 Sep 09;341:c4467
pubmed: 20829298
BMC Med. 2016 Oct 3;14(1):151
pubmed: 27716302
Menopause. 2018 Dec;25(12):1432-1441
pubmed: 29787482
JAMA Netw Open. 2019 Aug 2;2(8):e1910154
pubmed: 31461147
J Geriatr Phys Ther. 2007;30(1):8-15
pubmed: 19839175
J Gerontol A Biol Sci Med Sci. 2006 Jul;61(7):694-701
pubmed: 16870631
JCI Insight. 2019 Mar 7;4(5):
pubmed: 30843880
Menopause. 2008 Nov-Dec;15(6):1079-85
pubmed: 18520694
Ann Epidemiol. 2006 Jul;16(7):554-62
pubmed: 16406245
Age Ageing. 2011 Jan;40(1):14-23
pubmed: 20843964
Clin Chem Lab Med. 2014 Aug;52(8):1143-52
pubmed: 24622790
Obstet Gynecol Clin North Am. 2011 Sep;38(3):455-66
pubmed: 21961713
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Eur J Appl Physiol Occup Physiol. 1996;73(3-4):382-6
pubmed: 8781873
J Gerontol A Biol Sci Med Sci. 2009 Oct;64(10):1071-81
pubmed: 19561145
BMC Med. 2018 Feb 6;16(1):17
pubmed: 29402284
Climacteric. 2012 Apr;15(2):105-14
pubmed: 22338612
Ann N Y Acad Sci. 2010 Feb;1186:174-89
pubmed: 20201873
Age Ageing. 2000 May;29(3):235-42
pubmed: 10855906
BMC Geriatr. 2019 Aug 8;19(1):216
pubmed: 31395008
J Nutr Health Aging. 2000;4(3):156-61
pubmed: 10936902
Physiotherapy. 2011 Sep;97(3):182-9
pubmed: 21820535
Menopause. 2009 Sep-Oct;16(5):892-6
pubmed: 19455071
BMC Womens Health. 2020 Aug 14;20(1):177
pubmed: 32795281
Obstet Gynecol. 2007 Dec;110(6):1290-6
pubmed: 18055722
Am J Epidemiol. 2004 Sep 1;160(5):484-91
pubmed: 15321846

Auteurs

Fanny Kilpi (F)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK. fanny.kilpi@bristol.ac.uk.
Population Health Sciences, Bristol Medical School, Bristol, UK. fanny.kilpi@bristol.ac.uk.

Ana Goncalves Soares (AG)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Sciences, Bristol Medical School, Bristol, UK.

Gemma L Clayton (GL)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Sciences, Bristol Medical School, Bristol, UK.

Abigail Fraser (A)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Sciences, Bristol Medical School, Bristol, UK.
Bristol NIHR Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK.

Paul Welsh (P)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Naveed Sattar (N)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Scott M Nelson (SM)

Bristol NIHR Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK.
School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.

Kate Tilling (K)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Sciences, Bristol Medical School, Bristol, UK.
Bristol NIHR Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK.

Deborah A Lawlor (DA)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Population Health Sciences, Bristol Medical School, Bristol, UK.
Bristol NIHR Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH